Csaba Miskey

Dr. Csaba Miskey


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2019 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
IQIrma Querques
Irma Querques
AMAndreas Mades
Andreas Mades
CZCecilia Zuliani
Cecilia Zuliani
CMCsaba Miskey
Csaba Miskey
MAMiriam Alb
Miriam Alb
OBOrsolya Barabas
Orsolya Barabas

3 April 2019 in Mobile DNA
Verified
Journal Article
Open access
PDF file
APAntonio Palazzo
Antonio Palazzo
PLPatrizio Lorusso
Patrizio Lorusso
CMCsaba Miskey
Csaba Miskey
OWOliver Walisko
Oliver Walisko
AGAndrea Gerbino
Andrea Gerbino
RMRené Marsano
René Marsano
We have recently described a peculiar feature of the promoters in two Drosophila Tc1-like elements, Bari1 and Bari3. The AT-richness and the presence of weak core-promoter motifs make these promoters, that we have defined “blurry”, able to activate transcription of a reporter gene in cellular systems as diverse as fly, human, yeast and bacteria. In order to clarify whether the blurry promoter is a specific feature of the Bari transposon family, we have extended this study to promoters isolated from three additional DNA transposon and from two additional LTR retrotransposons. Here we show that the blurry promoter is also a feature of two vertebrate transposable elements, Sleeping Beauty and Hsmar1, belonging to the Tc1/mariner superfamily. In contrast, this feature is not shared by the promoter of the hobo transposon, which belongs to the hAT superfamily, nor by LTR retrotransposon-derived promoters, which, in general, do not activate transcription when introduced into non-related genomes. Our results suggest that the blurry promoter could be a shared feature of the members of the Tc1/mariner superfamily with possible evolutionary and biotechnological implications.

6 March 2020 in eLife
Verified
Journal Article
Open access
AKAdrian Kovač
Adrian Kovač
CMCsaba Miskey
Csaba Miskey
MMMichael Menzel
Michael Menzel
EGEsther Grueso
Esther Grueso
AGAndreas Gogol-Döring
Andreas Gogol-Döring
Zoltán IvicsZoltán Ivics
Zoltán Ivics
An ideal tool for gene therapy would enable efficient gene integration at predetermined sites in the human genome. Here we demonstrate biased genome-wide integration of the Sleeping Beauty (SB) transposon by combining it with components of the CRISPR/Cas9 system. We provide proof-of-concept that it is possible to influence the target site selection of SB by fusing it to a catalytically inactive Cas9 (dCas9) and by providing a single guide RNA (sgRNA) against the human Alu retrotransposon. Enrichment of transposon integrations was dependent on the sgRNA, and occurred in an asymmetric pattern with a bias towards sites in a relatively narrow, 300 bp window downstream of the sgRNA targets. Our data indicate that the targeting mechanism specified by CRISPR/Cas9 forces integration into genomic regions that are otherwise poor targets for SB transposition. Future modifications of this technology may allow the development of methods for specific gene insertion for precision genetic engineering.

6 November 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
Richard John Philip BrownRichard John Philip Brown
Richard John Philip Brown
BRBirthe Reinecke
Birthe Reinecke
JSJulie Sheldon
Julie Sheldon
TKTanvi Khera
Tanvi Khera
ANAnggakusuma
Anggakusuma
TPThomas Pietschmann
Thomas Pietschmann
Hepatitis C virus (HCV) has no animal reservoir, infecting only humans. To investigate species barrier determinants limiting infection of rodents, murine liver complementary DNA library screening was performed, identifying transmembrane proteins Cd302 and Cr1l as potent restrictors of HCV propagation. Combined ectopic expression in human hepatoma cells impeded HCV uptake and cooperatively mediated transcriptional dysregulation of a noncanonical program of immunity genes. Murine hepatocyte expression of both factors was constitutive and not interferon inducible, while differences in liver expression and the ability to restrict HCV were observed between the murine orthologs and their human counterparts. Genetic ablation of endogenous Cd302 expression in human HCV entry factor transgenic mice increased hepatocyte permissiveness for an adapted HCV strain and dysregulated expression of metabolic process and host defense genes. These findings highlight human-mouse differences in liver-intrinsic antiviral immunity and facilitate the development of next-generation murine models for preclinical testing of HCV vaccine candidates.

4 October 2022 in Cell Reports
Verified
Journal Article
Open access
MRMarcel G.E. Rommel
Marcel G.E. Rommel
LWLisa Walz
Lisa Walz
FFFoteini Fotopoulou
Foteini Fotopoulou
SKSaskia Kohlscheen
Saskia Kohlscheen
FSFranziska Schenk
Franziska Schenk
UMUte Modlich
Ute Modlich
Respiratory tract infections are among the deadliest communicable diseases worldwide. Severe cases of viral lung infections are often associated with a cytokine storm and alternating platelet numbers. We report that hematopoietic stem and progenitor cells (HSPCs) sense a non-systemic influenza A virus (IAV) infection via inflammatory cytokines. Irrespective of antiviral treatment or vaccination, at a certain threshold of IAV titer in the lung, CD41-positive hematopoietic stem cells (HSCs) enter the cell cycle while endothelial protein C receptor-positive CD41-negative HSCs remain quiescent. Active CD41-positive HSCs represent the source of megakaryocytes, while their multi-lineage reconstitution potential is reduced. This emergency megakaryopoiesis is thrombopoietin independent and attenuated in IAV-infected interleukin-1 receptor-deficient mice. Newly produced platelets during IAV infection are immature and hyper-reactive. After viral clearance, HSC quiescence is re-established. Our study reveals that non-systemic viral respiratory infection has an acute impact on HSCs via inflammatory cytokines to counteract IAV-induced thrombocytopenia.

8 February 2021 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
DSDan Shen
Dan Shen
Chengyi SongChengyi Song
Chengyi Song
CMCsaba Miskey
Csaba Miskey
SCShuheng Chan
Shuheng Chan
ZGZhongxia Guan
Zhongxia Guan
BGBo Gao
Bo Gao
New genetic tools and strategies are currently under development to facilitate functional genomics analyses. Here, we describe an active member of the Tc1/mariner transposon superfamily, named ZB, which invaded the zebrafish genome very recently. ZB exhibits high activity in vertebrate cells, in the range of those of the widely used transposons piggyBac (PB), Sleeping Beauty (SB) and Tol2. ZB has a similar structural organization and target site sequence preference to SB, but a different integration profile with respect to genome-wide preference among mammalian functional annotation features. Namely, ZB displays a preference for integration into transcriptional regulatory regions of genes. Accordingly, we demonstrate the utility of ZB for enhancer trapping in zebrafish embryos and in the mouse germline. These results indicate that ZB may be a powerful tool for genetic manipulation in vertebrate model species.